McKesson Corporation (MCK) has put up some notable numbers lately. Here is a data-driven look at its financials, valuation, and shareholder returns.
McKesson Corporation's Revenue Performance
McKesson Corporation posted revenue of $403.43B in FY2026, a 12.4% rise from $359.05B in FY2025.
Over 10 years, McKesson Corporation's revenue has compounded at 7.8% annually. That is not a breakout compounder, but it is steady enough to signal a durable underlying business.
A $403.43B revenue base firmly places McKesson Corporation in the large-cap tier among US health care companies.
Ten consecutive years of revenue moving in the same direction is a signal worth taking seriously. That kind of consistency points to structural demand, not a cyclical tailwind.
| Year | Revenue | YoY % |
|---|---|---|
| FY2026 | $403.43B | +12.4% |
| FY2025 | $359.05B | +16.2% |
| FY2024 | $308.95B | +11.7% |
| FY2023 | $276.71B | +4.8% |
| FY2022 | $263.97B | +10.8% |
View the detailed revenue trend and growth analysis
McKesson Corporation's Revenue Breakdown
Breaking down McKesson Corporation's revenue mix in FY2025 clarifies where the business actually generates its sales.
McKesson Corporation Business Segment Performance (FY2025)
| Segment | Revenue | % of Total |
|---|---|---|
| U.S. Pharmaceutical Segment | $327.72B | 91.3% |
| International Segment | $14.72B | 4.1% |
| Medical-Surgical Solutions Segment | $11.39B | 3.2% |
| Prescription Technology Solutions | $5.22B | 1.5% |
The dominant revenue source is U.S. Pharmaceutical Segment, which accounts for 91.3% of revenue and expanded 17.6% over the prior year.
Geographically, McKesson Corporation's sales are divided between United States (83%) and International (17%).
Profitability
Profitability improved meaningfully, with net income reaching $4.76B in FY2026, a 44.5% jump from FY2025.
Net profit margin came in at 1.2% in FY2026, roughly in line with prior periods.
Diluted earnings per share landed at $38.38 in FY2026, compared to $25.72 a year earlier.
Explore the profitability trend in detail below
Dividends & Buybacks
McKesson Corporation's FY2026 dividend was $3.07 per share, translating to a yield of 0.39%.
The dividend track record carries some weight: McKesson Corporation has sustained payouts for 10+ consecutive years.
A payout ratio of 8.0% leaves the company plenty of room to grow the dividend while keeping earnings available for reinvestment.
| Year | DPS | Payout Ratio |
|---|---|---|
| FY2026 | $3.07 | 8.0% |
| FY2025 | $2.69 | 10.5% |
| FY2024 | $2.34 | 10.5% |
| FY2023 | $2.05 | 8.2% |
| FY2022 | $1.80 | 24.9% |
Over 11 years, McKesson Corporation has returned $28.02B to shareholders through stock buybacks.
Explore McKesson Corporation's capital return activity in the charts below
McKesson Corporation Debt & Liquidity
| Metric | Value |
|---|---|
| Cash & Short-term Investments | $3.98B |
| Total Debt | $6.37B |
| Shareholders' Equity | -$2.17B |
| Total Assets | $82.32B |
| Debt-to-Equity Ratio | N/A (negative equity) |
| Current Ratio | 0.85x |
| Interest Coverage | 26.1x |
| Free Cash Flow (TTM) | $5.72B |
McKesson Corporation carries negative shareholder equity (equity deficit), a current ratio of 0.85, and interest coverage of 26.1x in FY2026. Taken together, these figures suggest adequate financial health with manageable leverage.
McKesson Corporation's shareholders' equity sits at negative $2.17B. That figure sounds alarming in isolation, but it is characteristic of businesses that aggressively return capital through buybacks, funded by consistent operating cash flows.
A current ratio of 0.85x signals a limited near-term liquidity cushion for McKesson Corporation.
With interest coverage at 26.1x, McKesson Corporation has substantial headroom above its debt obligations.
Free cash flow of $5.72B underscores the company's capacity to self-fund growth and continue returning capital to shareholders.
Dive into McKesson Corporation's balance sheet strength below
As of FY2026, McKesson Corporation employed 43,000 people, generating roughly $9.4M in revenue per employee.
Explore McKesson Corporation's headcount trend and workforce productivity
Is McKesson Corporation Overvalued?
Putting a fair value on McKesson Corporation requires running the numbers through multiple valuation lenses.
McKesson Corporation shares are currently trading at $827.14.
Applying the P/E Ratio model produces a fair value of $1,134 for McKesson Corporation.
Intrinsic value estimates using the DCF and EPS Growth models are also available. Sign up to see the full breakdown with fair value estimates.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | $1,134 | 27.1% upside to fair value |
| DCF | Upgrade | Upgrade |
| EPS Growth | Upgrade | Upgrade |
What Stands Out
Pulling it all together, here is what McKesson Corporation's (MCK) latest numbers actually tell investors.
FY2026 revenue came in at $403.43B, up 12.4% year-over-year.
Over a 10-year horizon, revenue has compounded at 7.8% annually.
The business is profitable, generating a net margin of 1.2% and net income of $4.76B.
McKesson Corporation returned $5.13B to shareholders in FY2026 through dividends and/or buybacks.
Shareholders' equity is negative, which in this case reflects an aggressive buyback program in a company with strong underlying cash flows.
The P/E Ratio model implies 27.1% upside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.
The charts and valuation models further down the page offer a closer look at McKesson Corporation's financial trajectory.